Medical Marijuana, Inc. (MJNA)

MJNA-LOGOMedical Marijuana, Inc. is comprised of a diversified portfolio of products, technology, businesses, and services exclusively focused on the production of high concentrate hemp oil products that are rich in cannabinoid (CBD). The company’s products range from proprietary and patented cannabinoid-based products to seed and stalk, or isolated high-value extracts formulated and manufactured for the nutraceutical, pharmaceutical, cosmeceutical, and food industries.

The services offered by Medical Marijuana, Inc. are extensive and varied. Such services range from medical clinic management to the capitalization of existing businesses and product leaders in the industry. The company also provides development of CBD-based health and wellness products and of medical-grade compounds.

Medical Marijuana, Inc. provides more than 85 proprietary and patent-pending delivery methods of cannabinoid that are more acceptable both medically and socially than the typical delivery methods in the industry. The company’s services also include licensing of its proprietary testing, packaging, genetics, labeling, production, tracking, and standardization methods for the medicinal herb industry.

The California-based Medical Marijuana, Inc. has an impressive portfolio of businesses that includes HempMeds PX, CanChew Gum, Canipa Holdings, Phytosphere, KannaLife Sciences, Red Dice Holdings, and Wellness Managed Services. These businesses, whether wholly or partially owned by Medical Marijuana, Inc., are integral pieces of the company’s business. The company’s featured products include Real Scientific Hemp Oil, Cibdex, Cibaderm, and Dixie Botanicals.

Founded in 2003, Medical Marijuana, Inc. is a publicly traded holding company that trades in the OTC market under the stock symbol MJNA. The company’s mission is to become the premier innovators in the hemp and cannabis industry, leveraging their team of professionals into sourcing, evaluating, and purchasing value-added products and companies while allowing them to retain their entrepreneurial spirit and integrity. Medical Marijuana, Inc. strives to create awareness within the industry, develop economically-stable and environmentally-friendly businesses while increasing shareholder value.


Yahoo! Finance: MJNA News

Latest Financial News for MJNA

Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc.'s Cannabinoid Oral Care Products Registered For Use In Clinical Trials Through Australian Healthcare Partner

NEW YORK , June 26, 2019 /PRNewswire/ -- Medical Marijuana, Inc.  (OTC: MJNA ) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...

Dixie Botanicals®, Subsidiary of Medical Marijuana, Inc., Announces Partnership with Surface Products Corp. To Sell Fitness-Focused CBD-Infused Sunscreen

SAN DIEGO, June 21, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Dixie Botanicals® has partnered with Surface Products Corp. to sell a fitness-focused hemp-derived CBD sunscreen for active consumers.

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Third Series of Cannabinoid Medicine Courses in São Paulo

- The company's Brazilian subsidiary is launching its third series of courses to teach doctors about cannabinoids, the endocannabinoid system and potential therapeutic uses of cannabidiol (CBD) in Brazil ...

Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc. Moves Forward on Oral Healthcare Line With Cannabinoid Product Supply Agreement

SAN DIEGO , June 13, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC:MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...

Medical Marijuana, Inc. Announces Completion of the First-Ever High-Level Stability Study on a CBD Hemp Oil Product

SAN DIEGO, June 12,  2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company has reached a major milestone for long-term stability testing on its flagship THC-free cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-XTM). "We're excited to offer consumers and retail partners the transparency and security of knowing that our products are reliable and stable throughout several climatic conditions and through transportation," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. This helps the company ensure to its customers and retailers that the integrity of the product will not be compromised while in transportation or while being stored for future use," said Medical Marijuana, Inc. Vice President of Project Analysis and R&D, Dr. Levan Darjania.